SUBSCRIBE
SUBSCRIBE
News   FDA

Novartis International AG Diabetes Drug Galvus Approved in Europe

September 28, 2007 | 
1 min read
ZURICH, Sept 28 (Reuters) - Novartis AG's (NOVN.VX: Quote, Profile, Research) potential blockbuster diabetes treatment Galvus has been approved for use in the European Union, the Swiss drugmaker said on Friday.
FDA Approvals Europe
MORE ON THIS TOPIC
Pictured: Johnson & Johnson Business Center in Switzerland
Immuno-oncology
J&J Wins Third National Priority Approval for Multiple Myeloma Combo
March 6, 2026
 · 
2 min read
 · 
Tristan Manalac
Human brain with abstract visualization of neuron activity
Huntington’s disease
FDA Official Fires Back at UniQure, Doubles Down on Sham-Controlled Trial
March 6, 2026
 · 
2 min read
 · 
Tristan Manalac
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
FDA
FDA’s Hoeg Reportedly Trying To Hire Friend, Fellow Antidepressant Skeptic
March 5, 2026
 · 
2 min read
 · 
Tristan Manalac
Business decision concept with a businessman standing on a huge question mark. Symbol of the future, opportunities, planning, vision. Vector illustration
Regulatory
PepGen’s Mid-Stage Myotonic Dystrophy Study Hit With ‘Surprise’ Pause
March 5, 2026
 · 
2 min read
 · 
Tristan Manalac